Constipation Treatment Market Outlook Signals Expansion To $18.71 Billion Through 2030

The constipation treatment market is on track for significant expansion over the coming years, driven by various factors that are reshaping how this condition is managed. As awareness about gut health grows and new therapeutic options emerge, the industry is poised for robust development. Let's explore the current market size, key contributors to growth, prominent players, emerging trends, and the main segments defining this sector.

Projected Growth and Market Valuation of the Constipation Treatment Market
The constipation treatment market is expected to reach $18.72 billion by 2030, growing at a steady compound annual growth rate (CAGR) of 8.0%. This upward trajectory is driven by multiple factors, including an increase in chronic constipation cases, more widespread opioid use, heightened awareness around gut health, and expansion in specialty gastroenterology services. Additionally, improved access to innovative therapies is helping fuel this positive outlook. Noteworthy trends anticipated during this period include rising reliance on prescription treatments for chronic constipation, an increasing preference for probiotics and gut-supportive products, a shift toward drugs targeting specific mechanisms, greater attention to managing opioid-induced constipation, and growing distribution through online pharmacy channels.

The constipation treatment market size has grown strongly in recent years. It will grow from $12.71 billion in 2025 to $13.75 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to high prevalence of gastrointestinal disorders, sedentary lifestyle patterns, dietary fiber deficiency, reliance on traditional laxatives, aging population growth.

Download a free sample of the constipation treatment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12134&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Factors Fueling Growth in the Constipation Treatment Market
The rising prevalence of chronic constipation globally has become a major factor in market expansion. This condition, often linked with lifestyle, dietary habits, and aging populations, is prompting more patients to seek effective solutions.
Another important driver is the growing use of opioids, which commonly cause constipation as a side effect. This has led to a focused demand for therapies specifically designed to counter opioid-induced constipation, encouraging innovation and targeted approaches in treatment options.

Top Companies Leading the Constipation Treatment Industry
The market features several key players shaping the future of constipation treatment. Prominent companies include Pfizer, Johnson & Johnson, AbbVie, Bayer, Sanofi, Fresenius Kabi, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Bausch Health Companies Inc, Salix Pharmaceuticals Inc, Prestige Consumer Healthcare Inc, Ironwood Pharmaceuticals Inc, Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, Probi AB, 4D Pharma plc, Abbott Laboratories, Albireo Pharma Inc, Ardelyx Inc, Synergy Pharmaceuticals Inc, Astellas Pharma Inc, and Allergan plc.
A significant acquisition occurred in March 2023, when Ipsen, a pharmaceutical company based in France, acquired the US biotech firm Albireo Pharma Inc. Although the financial details were not disclosed, this move strengthens Ipsen's portfolio in rare diseases, particularly focusing on chronic constipation drug development.

View the full constipation treatment market report:
https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Innovations Shaping the Constipation Treatment Market
Key players are increasingly exploring new, non-traditional treatment modalities to meet patient demand for effective therapies with fewer side effects. One such innovation is mechanical stimulation capsules, which work without drugs to promote bowel movements.
For example, a vibrating capsule is a swallowable device containing a small motor and battery within a medical-grade, excretable shell. It provides timed mechanical stimulation to the colon to induce predictable peristalsis without the systemic impacts typical of laxatives or prokinetics.
In May 2023, Vibrant Ltd., a US-based medical technology company, introduced Vibrant, an FDA-cleared, prescription-only vibrating capsule system aimed at adults with chronic idiopathic constipation who have not responded well to laxatives. The system features a reusable activation pod and a single-use capsule, which delivers approximately 190 short vibration cycles per hour to encourage colonic contractions.

Segment Breakdown Within the Constipation Treatment Market
This market is categorized by several important segments to better understand product and application diversity:
1) Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists (PAMORAs), Guanylate Cyclase-C (GC-C) Agonists, and other therapeutics.
2) Disease Types: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome with Constipation (IBS-C), and Opioid-Induced Constipation (OIC).
3) Distribution Channels: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
Further subcategories include:
- Laxatives: Bulk-Forming, Osmotic, Stimulant, and Stool Softeners.
- Chloride Channel Activators: Lubiprostone-based formulations and others.
- PAMORAs: Methylnaltrexone, Naloxegol, and other formulations.
- GC-C Agonists: Linaclotide, Plecanatide, and other drugs in this class.
- Other Therapeutics: Prokinetic agents, Serotonin 5-HT4 receptor agonists, and herbal or alternative options.

This detailed segmentation helps stakeholders understand the diverse approaches being employed to treat constipation as well as the channels through which these treatments reach patients.

Expanded capabilities in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.